Death due to haemorrhage (bleeding) is a preventable death. Yet 30-40% of people in a civilian setting die as a result of bleeding to death. In a military setting 90% of casualties with potentially survivable injuries die due to haemorrhage. This project will specifically target this clinical need, through the design, construction and testing of this portable efficacious haemostatic agent/dressing to control bleeding. We are employing potent snake venom proteins to bring about rapid and stable blood clot formation in combination with biomaterials to target specific wound types.

Related sources

Funding boost brings life-saving 'venom' gel device a step closer

Deadly snakes could save your life



Professor Alan Rowan
AIBN Institute Director
Senior Group Leader, Rowan Group

Dr Amanda Kijas
Senior Research Fellow, Rowan Group

Learn more about the
Rowan Group

Start your PhD journey
with AIBN